Vir Biotechnology (VIR) Other financing activities (2019 - 2025)
Vir Biotechnology recorded quarterly Other financing activities of -$2000.0 in Q4 2025, down 300.0% quarter-over-quarter from $1000.0 in Q3 2025, and down 115.38% year-over-year from $13000.0 in Q4 2024.
Vir Biotechnology's Other financing activities history runs 5 years deep, the most recent figure standing at -$2000.0 for Q4 2025.
- In Q4 2025, Other financing activities fell 115.38% year-over-year to -$2000.0; the TTM figure through Dec 2025 stood at -$28000.0 (up 83.03% YoY), while the FY2025 annual figure was -$361000.0, down 118.79% from the prior year.
- Other financing activities came in at -$2000.0 for Q4 2025 at Vir Biotechnology, down from $1000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $100000.0 in Q1 2023 to a low of -$387000.0 in Q4 2023.
- A 4-year average of -$89125.0 and a median of -$21000.0 in 2024 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities soared 103.36% in 2024 and plunged 115.38% in 2025, its largest moves.
- Vir Biotechnology's Other financing activities stood at -$260000.0 in 2022, then sank by 48.85% to -$387000.0 in 2023, then jumped by 103.36% to $13000.0 in 2024, then slumped by 115.38% to -$2000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered -$2000.0, $1000.0, and $13000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -138,000.00 |
| Jun 30, 2024 | -138,000.00 |
| Dec 31, 2023 | -387,000.00 |
| Dec 31, 2023 | -387,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | -260,000.00 |
| Dec 31, 2022 | -260,000.00 |
| Sep 30, 2019 | 3.06 Mn |
| Sep 30, 2019 | 3.06 Mn |